Zhen Teng Liu
Directeur Général chez SHANDONG LUOXIN PHARMACY GROUP CO LTD
Fortune : 3 M $ au 30/04/2024
Profil
Zhen Teng Liu is currently the Chairman & General Manager at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
and Luoxin Pharmaceuticals Group Stock Co., Ltd.
He started his current positions in 2013 and 2020 respectively.
In terms of education, Mr. Liu holds an MBA from The University of New South Wales and an undergraduate degree from Macquarie University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/07/2023 | 4 689 648 ( 0,96% ) | 3 M $ | 30/04/2024 |
Postes actifs de Zhen Teng Liu
| Sociétés | Poste | Début |
|---|---|---|
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Directeur Général | 31/01/2023 |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Directeur Général | 23/04/2023 |
Formation de Zhen Teng Liu
| Macquarie University | Undergraduate Degree |
| The University of New South Wales | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
